Article

Estimation of the Stage-Wise Costs of Breast Cancer in Germany Using a Modeling Approach

2022-07-08

Abstract excerpt

Breast cancer (BC) is a heterogeneous disease representing a substantial economic burden. In order to develop policies that successfully decrease this burden, the factors affecting costs need to be fully understood. Evidence suggests that early detection in Stage I has a lower cost than late detection. We aim to provide conservative estimates of BC's stage-wise medical costs from German healthcare and the payer's...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: cb5397e8-1d31-57c4-99e7-06aa28d0d10a
DOI: 10.20944/preprints202207.0140.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Estimation of the Stage-Wise Costs of Breast Cancer in Germany Using a Modeling ApproachDOI 10.20944/preprints202207.0140.v1Read

Who Bears the Highest Costs of Breast Cancer? A Cost-of-Illness Study in Poland from a Societal PerspectiveSemantic proximity Read

Costs of Breast Cancer Treatment Incurred by Women in VietnamSemantic proximity Read

Cost-utility analysis of genomic profiling in early breast cancer in ColombiaSemantic proximity Read

Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations.Semantic proximity Read

Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation.Semantic proximity Read

Cost-utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland.Semantic proximity Read

Measuring the economic burden of breast cancer in middle-income countries: Protocol for a prospective cohort study in India and KenyaSemantic proximity Read

Cost-effectiveness of Trastuzumab emtansine and Capecitabine plus lapatinib in adjuvant treatment of Human Epidermal Growth Factor Receptor 2– Positive Metastatic Breast Cancer in ChinaSemantic proximity Read

Cost-Effectiveness Analysis of Genomic Profiling in Early Breast Cancer in ColombiaSemantic proximity Read

Modelling breast cancer: one size does not fit allSemantic proximity Read

Personalizing mammography by breast density and other risk factors for breast cancer: analysis of health benefits and cost-effectiveness.Semantic proximity Read

Estimation of healthcare-related charges in women with BRCA mutations and breast cancer.Semantic proximity Read